Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CRDL

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRDL
DateTimeSourceHeadlineSymbolCompany
27/02/202402:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
21/02/202423:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
16/02/202405:15AllPennyStocks.comOrphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company SoaringNASDAQ:CRDLCardiol Therapeutics Inc
15/02/202423:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
24/01/202423:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
09/01/202423:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
05/12/202323:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
16/11/202322:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
01/11/202322:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
21/10/202308:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
12/10/202301:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
10/10/202321:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
26/09/202321:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
21/09/202300:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
19/09/202321:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
11/08/202307:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
09/08/202322:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
08/08/202321:38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
30/06/202301:45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
30/06/202301:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
27/06/202321:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
19/05/202306:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
16/05/202306:55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
29/03/202322:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
29/03/202321:02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CRDLCardiol Therapeutics Inc
07/03/202323:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
12/12/202223:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
20/11/202219:35TipRanksCardiol Therapeutics (CRDL) Receives a Rating Update from a Top AnalystNASDAQ:CRDLCardiol Therapeutics Inc
20/11/202219:15TipRanksCanaccord Genuity Sticks to Their Buy Rating for Cardiol Therapeutics (CRDL)NASDAQ:CRDLCardiol Therapeutics Inc
15/11/202209:35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CRDL